Gebrael, Georges http://orcid.org/0000-0002-4085-6415
Sayegh, Nicolas http://orcid.org/0000-0003-1924-8148
Thomas, Vinay Mathew
Chigarira, Beverly
Tripathi, Nishita
Jo, Yeon Jung
Li, Haoran
Sahu, Kamal Kant
Srivastava, Ayana
McFarland, Taylor
Maughan, Benjamin L.
Swami, Umang
Agarwal, Neeraj http://orcid.org/0000-0003-1076-0428
Article History
Received: 4 May 2023
Revised: 19 June 2023
Accepted: 5 July 2023
First Online: 17 July 2023
Change Date: 24 August 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41391-023-00706-x
Competing interests
: Neeraj Agarwal, MD: NA does not report any personal COI since April 15, 2021. However, the following are his lifetime personal COIs: Consultancy to Astellas, Astra Zeneca, Aveo, Bayer, Bristol Myers Squibb, Calithera, Clovis, Eisai, Eli Lilly, EMD Serono, Exelixis, Foundation Medicine, Genentech, Gilead, Janssen, Merck, MEI Pharma, Nektar, Novartis, Pfizer, Pharmacyclics, and Seattle Genetics. Research funding to Neeraj Agarwal’s institution: Arnivas, Astellas, Astra Zeneca, Bavarian Nordic, Bayer, Bristol Myers Squibb, Calithera, Celldex, Clovis, Crispr, Eisai, Eli Lilly, EMD Serono, Exelixis, Genentech, Gilead, Glaxo Smith Kline, Immunomedics, Janssen, Lava, Medivation, Merck, Nektar, Neoleukin, New Link Genetics, Novartis, Oric, Pfizer, Prometheus, Rexahn, Roche, Sanofi, Seattle Genetics, Takeda, and Tracon. Umang Swami, MD: has been paid for a consulting or advisory role by Seattle Genetics, Astellas Pharma, Exelixis, Imvax, and AstraZeneca, currently or during the past 2 years. Dr. Swami’s institution has received research funding from Janssen, Seattle Genetics/Astellas, and Exelixis, currently or within the past 2 years. Benjamin L. Maughan, MD: is a paid consultant/advisor to Abbvie, Pfizer, AVEO oncology, Janssen, Astellas, Bristol-Myers Squibb, Clovis, Tempus, Merck, Exelixis, Bayer Oncology and Peloton Therapeutics; Huntsman Cancer Institute has received research funding from Exelixis (Inst), Bavarian-Nordic (Inst), Clovis (Inst), Genentech (Inst) and Bristol-Myers Squibb (Inst) on his behalf.